{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T02:08:37Z","timestamp":1762999717425,"version":"3.37.3"},"reference-count":66,"publisher":"Bentham Science Publishers Ltd.","issue":"3","funder":[{"DOI":"10.13039\/501100009553","name":"Czech Health Research Council, Czech Republic","doi-asserted-by":"publisher","award":["NV18-04-00455"],"award-info":[{"award-number":["NV18-04-00455"]}],"id":[{"id":"10.13039\/501100009553","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CAR"],"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Insulin-degrading enzyme (IDE) is a widely distributed Zn2+-binding metalloprotease\nthat cleaves multiple short and medium-sized peptides prone to form \u03b2-structures. These\ninclude insulin and amyloid-\u03b2 peptides. Accumulation and fibrillation of amyloid-\u03b2 peptides leading\nto the formation of amyloid plaques is a characteristic sign of Alzheimer\u2019s disease (AD) pathology.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>The study investigated the rs2421943 single nucleotide polymorphism (SNP) of the IDE\ngene as a risk factor for MCI (mild cognitive impairment) and AD.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>Two independent groups of 1670 patients and controls were included. The AD group consisted of 595 patients and 400 controls; the MCI group involved 135 patients and 540 matched controls. PCR and restriction fragment length analysis was used for analysis of the rs2421943 polymorphism. Using the miRBase and RNA22 prediction tools in silico indicated that the rs2421943 polymorphism is a potential target for a specific miRNA (hsa-miR-7110-5p).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>AG and GG genotypes of rs2421943 significantly increased the risk of AD, and the AG genotype\nincreased the risk of MCI. It seems the G allele both increases the risk of AD and accelerates the\ntransition through the MCI phase. In silico study revealed that rs2421943 is inside the sequence binding\nmiRNA hsa-miR-7110-5p. The polymorphism could affect the rate of IDE pre-RNA (heterogeneous\nnuclear RNA, hnRNA) processing, resulting in slower translation, lower levels of IDE, deficient\nremoval of amyloid-\u03b2 fragments, and greater risk of and\/or accelerated progression of AD.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusions:<\/jats:title>\n<jats:p>GG and AG genotypes of the single nucleotide polymorphism rs2421943 of insulindegrading\nenzyme gene increase the risk of AD and MCI.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1567205019666220302120950","type":"journal-article","created":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T06:38:38Z","timestamp":1646289518000},"page":"236-245","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Polymorphism Rs2421943 of the Insulin-Degrading Enzyme Gene and the\nRisk of Late-Onset Alzheimer\u2019s Disease"],"prefix":"10.2174","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6062-8997","authenticated-orcid":true,"given":"Omar","family":"\u0160er\u00fd","sequence":"first","affiliation":[{"name":"Laboratory of Neurobiology and Molecular Psychiatry, Department of Biochemistry, Faculty of Science, Masaryk University,\nBrno 62500, Czech Republic"},{"name":"Laboratory of Neurobiology and Pathological Physiology, Institute of Animal Physiology\nand Genetics, Czech Academy of Sciences, Brno, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom\u00e1\u0161","family":"Zeman","sequence":"additional","affiliation":[{"name":"Laboratory of Neurobiology and Molecular Psychiatry, Department of Biochemistry, Faculty of Science, Masaryk University,\nBrno 62500, Czech Republic"},{"name":"Laboratory of Neurobiology and Pathological Physiology, Institute of Animal Physiology\nand Genetics, Czech Academy of Sciences, Brno, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"H\u00e1lov\u00e1","sequence":"additional","affiliation":[{"name":"Laboratory of Neurobiology and Molecular Psychiatry, Department of Biochemistry, Faculty of Science, Masaryk University,\nBrno 62500, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladim\u00edr","family":"Janout","sequence":"additional","affiliation":[{"name":"Department of Healthcare Management and Public Health, Faculty of Health Sciences, Palack\u00fd University Olomouc, Olomouc, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jana","family":"Janoutov\u00e1","sequence":"additional","affiliation":[{"name":"Department of Healthcare Management and Public\nHealth, Faculty of Health Sciences, Palack\u00fd University Olomouc; Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Lochman","sequence":"additional","affiliation":[{"name":"Laboratory of Neurobiology and Molecular Psychiatry, Department of Biochemistry, Faculty of Science, Masaryk University,\nBrno 62500, Czech Republic"},{"name":"Laboratory of Neurobiology and Pathological Physiology, Institute of Animal Physiology\nand Genetics, Czech Academy of Sciences, Brno, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladimir J.","family":"Balcar","sequence":"additional","affiliation":[{"name":"Laboratory of Neurobiology and Pathological Physiology, Institute of Animal Physiology\nand Genetics, Czech Academy of Sciences, Brno, Czech Republic"},{"name":"Neuroscience Theme, School of\nMedical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s00401-011-0826-y","volume":"121","author":"Nelson P.T.","year":"2011","unstructured":"Nelson P.T.; Head E.; Schmitt F.A.; Alzheimer's disease is not \u201cbrain aging\u201d: Neuropathological, genetic, and epidemiological human studies. Acta Neuropathol 2011,121(5),571-587","journal-title":"Acta Neuropathol"},{"key":"ref=2","first-page":"359","volume":"35","author":"\u0160er\u00fd O.","year":"2014","unstructured":"\u0160er\u00fd O.; Povov\u00e1 J.; Balcar V.J.; Perspectives in genetic prediction of Alzheimer's disease. Neuroendocrinol Lett 2014,35(5),359-366","journal-title":"Neuroendocrinol Lett"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5114\/fn.2013.34190","volume":"51","author":"\u0160er\u00fd O.","year":"2013","unstructured":"\u0160er\u00fd O.; Povov\u00e1 J.; M\u00ed\u0161ek I.; Pe\u0161\u00e1k L.; Janout V.; Molecular mechanisms of neuropathological changes in Alzheimer's disease: A review. Folia Neuropathol 2013,51(1),1-9","journal-title":"Folia Neuropathol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1016\/j.jalz.2019.05.011","volume":"15","author":"Huq A.J.","year":"2019","unstructured":"Huq A.J.; Fransquet P.; Laws S.M.; Genetic resilience to Alzheimer's disease in APOE \u03b54 homozygotes: A systematic review. Alzheimer's Dement 2019,15(12),1612-1623","journal-title":"Alzheimer's Dement"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"108","DOI":"10.5507\/bp.2012.055","volume":"156","author":"Povov\u00e1 J.","year":"2012","unstructured":"Povov\u00e1 J.; Ambroz P.; Bar M.; Epidemiological of and risk factors for Alzheimer's disease: A review. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2012,156(2),108-114","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"key":"ref=6","first-page":"691","volume":"35","author":"\u0160er\u00fd O.","year":"2014","unstructured":"\u0160er\u00fd O.; Hlineck\u00e1 L.; Balcar V.J.; Janout V.; Povov\u00e1 J.; Diabetes, hypertension and stroke - Does Alzheimer protect you? Neuroendocrinol Lett 2014,35(8),691-696","journal-title":"Neuroendocrinol Lett"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.biochi.2017.01.009","volume":"135","author":"\u0160er\u00fd O.","year":"2017","unstructured":"\u0160er\u00fd O.; Janoutov\u00e1 J.; Ewerlingov\u00e1 L.; CD36 gene polymorphism is associated with Alzheimer's disease. Biochimie 2017,135,46-53","journal-title":"Biochimie"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.pneurobio.2018.12.006","volume":"174","author":"Sharma P.","year":"2019","unstructured":"Sharma P.; Srivastava P.; Seth A.; Tripathi P.N.; Banerjee A.G.; Shrivastava S.K.; Comprehensive review of mechanisms of pathogenesis involved in Alzheimer's disease and potential therapeutic strategies. Prog Neurobiol 2019,174,53-89","journal-title":"Prog Neurobiol"},{"key":"ref=9","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-015746","volume":"7","author":"Bature F.","year":"2017","unstructured":"Bature F.; Guinn B.A.; Pang D.; Pappas Y.; Signs and symptoms preceding the diagnosis of Alzheimer's disease: A systematic scoping review of literature from 1937 to 2016. BMJ Open 2017,7(8)","journal-title":"BMJ Open"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/joim.12190","volume":"275","author":"Petersen R.C.","year":"2014","unstructured":"Petersen R.C.; Caracciolo B.; Brayne C.; Gauthier S.; Jelic V.; Fratiglioni L.; Mild cognitive impairment: A concept in evolution. J Intern Med 2014,275(3),214-228","journal-title":"J Intern Med"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"365","DOI":"10.21101\/cejph.a4414","volume":"23","author":"Janoutov\u00e1 J.","year":"2015","unstructured":"Janoutov\u00e1 J.; \u0160er\u00fd O.; Hos\u00e1k L.; Janout V.; Is mild cognitive impairment a precursor of Alzheimer's disease? Short review. Cent Eur J Public Health 2015,23(4),365-367","journal-title":"Cent Eur J Public Health"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/S0140-6736(06)68542-5","volume":"367","author":"Gauthier S.","year":"2006","unstructured":"Gauthier S.; Reisberg B.; Zaudig M.; International Psychogeriatric Association Expert Conference on mild cognitive impairment. Lancet 2006,367(9518),1262-1270","journal-title":"Lancet"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13195-019-0480-5","volume":"11","author":"Shimada H.","year":"2019","unstructured":"Shimada H.; Doi T.; Lee S.; Makizako H.; Reversible predictors of reversion from mild cognitive impairment to normal cognition: A 4-year longitudinal study. Alzheimer's Res Ther 2019,11,24","journal-title":"Alzheimer's Res Ther"},{"key":"ref=14","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/369808","volume":"2012","author":"Reitz C.","year":"2012","unstructured":"Reitz C.; Alzheimer's disease and the amyloid cascade hypothesis: A critical review. Int J Alzheimer's Dis 2012,2012","journal-title":"Int J Alzheimer's Dis"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"14537","DOI":"10.1523\/JNEUROSCI.2692-08.2008","volume":"28","author":"Puzzo D.","year":"2008","unstructured":"Puzzo D.; Privitera L.; Leznik E.; Picomolar amyloid-beta positively modulates synaptic plasticity and memory in hippocampus. J Neurosci 2008,28(53),14537-14545","journal-title":"J Neurosci"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s12264-013-1422-z","volume":"30","author":"Dorey E.","year":"2014","unstructured":"Dorey E.; Chang N.; Liu Q.Y.; Yang Z.; Zhang W.; Apolipoprotein E, amyloid-beta, and neuroinflammation in Alzheimer's disease. Neurosci Bull 2014,30(2),317-330","journal-title":"Neurosci Bull"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1111\/febs.14004","volume":"284","author":"Hardy J.","year":"2017","unstructured":"Hardy J.; The discovery of Alzheimer-causing mutations in the APP gene and the formulation of the \u201camyloid cascade hypothesis\u201d. FEBS J 2017,284(7),1040-1044","journal-title":"FEBS J"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1002\/alz.12005","volume":"16","author":"Jia L.","year":"2020","unstructured":"Jia L.; Fu Y.; Shen L.; PSEN1, PSEN2, and APP mutations in 404 Chinese pedigrees with familial Alzheimer's disease. Alzheimer's Dement 2020,16(1),178-191","journal-title":"Alzheimer's Dement"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/alzrt187","volume":"5","author":"Wildsmith K.R.","year":"2013","unstructured":"Wildsmith K.R.; Holley M.; Savage J.C.; Skerrett R.; Landreth G.E.; Evidence for impaired amyloid \u03b2 clearance in Alzheimer's disease. Alzheimer's Res Ther 2013,5(4),33","journal-title":"Alzheimer's Res Ther"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1021\/acs.biochem.6b00783","volume":"56","author":"Kurochkin I.V.","year":"2017","unstructured":"Kurochkin I.V.; Guarnera E.; Wong J.H.; Eisenhaber F.; Berezovsky I.N.; Toward allosterically increased catalytic activity of insulin-degrading enzyme against amyloid peptides. Biochemistry 2017,56(1),228-239","journal-title":"Biochemistry"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1016\/j.neurobiolaging.2006.06.017","volume":"28","author":"Bj\u00f6rk B.F.","year":"2007","unstructured":"Bj\u00f6rk B.F.; Katzov H.; Kehoe P.; Positive association between risk for late-onset Alzheimer disease and genetic variation in IDE. Neurobiol Aging 2007,28(9),1374-1380","journal-title":"Neurobiol Aging"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.neurobiolaging.2004.07.011","volume":"26","author":"Blomqvist M.E.L.","year":"2005","unstructured":"Blomqvist M.E.L.; Chalmers K.; Andreasen N.; Sequence variants of IDE are associated with the extent of beta-amyloid deposition in the Alzheimer's disease brain. Neurobiol Aging 2005,26(6),795-802","journal-title":"Neurobiol Aging"},{"key":"ref=23","first-page":"10","volume":"20","author":"Broh-Kahn R.H.","year":"1949","unstructured":"Broh-Kahn R.H.; Mirsky I.A.; The inactivation of insulin by tissue extracts; the effect of fasting on the insulinase content of rat liver. Arch Biochem 1949,20(1),10-14","journal-title":"Arch Biochem"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1074\/jbc.M112.393108","volume":"288","author":"Tundo G.R.","year":"2013","unstructured":"Tundo G.R.; Sbardella D.; Ciaccio C.; Insulin-degrading enzyme (IDE): A novel heat shock-like protein. J Biol Chem 2013,288(4),2281-2289","journal-title":"J Biol Chem"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3233\/JAD-2010-1206","volume":"19","author":"Bulloj A.","year":"2010","unstructured":"Bulloj A.; Leal M.C.; Xu H.; Casta\u00f1o E.M.; Morelli L.; Insulin-degrading enzyme sorting in exosomes: A secretory pathway for a key brain amyloid-beta degrading protease. J Alzheimer's Dis 2010,19(1),79-95","journal-title":"J Alzheimer's Dis"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jchemneu.2007.12.001","volume":"35","author":"Bernstein H.G.","year":"2008","unstructured":"Bernstein H.G.; Lendeckel U.; Bukowska A.; Regional and cellular distribution patterns of insulin-degrading enzyme in the adult human brain and pituitary. J Chem Neuroanat 2008,35(2),216-224","journal-title":"J Chem Neuroanat"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1080\/15548627.2016.1159375","volume":"12","author":"Son S.M.","year":"2016","unstructured":"Son S.M.; Cha M.Y.; Choi H.; Insulin-degrading enzyme secretion from astrocytes is mediated by an autophagy-based unconventional secretory pathway in Alzheimer disease. Autophagy 2016,12(5),784-800","journal-title":"Autophagy"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1016\/S0002-9440(10)63229-4","volume":"164","author":"Farris W.","year":"2004","unstructured":"Farris W.; Mansourian S.; Leissring M.A.; Partial loss-of-function mutations in insulin-degrading enzyme that induce diabetes also impair degradation of amyloid beta-protein. Am J Pathol 2004,164(4),1425-1434","journal-title":"Am J Pathol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"4903","DOI":"10.1021\/acs.biochem.8b00474","volume":"57","author":"Stefanidis L.","year":"2018","unstructured":"Stefanidis L.; Fusco N.D.; Cooper S.E.; Smith-Carpenter J.E.; Alper B.J.; Molecular determinants of substrate specificity in human insulin-degrading enzyme. Biochemistry 2018,57(32),4903-4914","journal-title":"Biochemistry"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"3644","DOI":"10.2174\/138161209789271799","volume":"15","author":"Fern\u00e1ndez-Gamba A.","year":"2009","unstructured":"Fern\u00e1ndez-Gamba A.; Leal M.C.; Morelli L.; Casta\u00f1o E.M.; Insulin-degrading enzyme: Structure-function relationship and its possible roles in health and disease. Curr Pharm Des 2009,15(31),3644-3655","journal-title":"Curr Pharm Des"},{"key":"ref=31","volume":"38","author":"Li H.J.","year":"2018","unstructured":"Li H.J.; Wu J.; Zhu L.F.; Insulin degrading enzyme contributes to the pathology in a mixed model of Type 2 diabetes and Alzheimer's disease: Possible mechanisms of IDE in T2D and AD. Bioscience Rep 2018,38","journal-title":"Bioscience Rep"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/s11892-014-0476-2","volume":"14","author":"Jayaraman A.","year":"2014","unstructured":"Jayaraman A.; Pike C.J.; Alzheimer's disease and type 2 diabetes: Multiple mechanisms contribute to interactions. Curr Diab Rep 2014,14(4),476","journal-title":"Curr Diab Rep"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.neurobiolaging.2006.03.009","volume":"28","author":"Mueller J.C.","year":"2007","unstructured":"Mueller J.C.; Riemenschneider M.; Schoepfer-Wendels A.; Weak independent association signals between IDE polymorphisms, Alzheimer's disease and cognitive measures. Neurobiol Aging 2007,28(5),727-734","journal-title":"Neurobiol Aging"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"760","DOI":"10.2174\/1567205014666170203100734","volume":"14","author":"da Costa I.B.","year":"2017","unstructured":"da Costa I.B.; de Labio R.W.; Rasmussen L.T.; Change in INSR, APBA2 and IDE gene expressions in brains of Alzheimer's disease patients. Curr Alzheimer Res 2017,14(7),760-765","journal-title":"Curr Alzheimer Res"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"610","DOI":"10.2174\/1567205015666180119105446","volume":"15","author":"Zhang H.","year":"2018","unstructured":"Zhang H.; Liu D.; Huang H.; Zhao Y.; Zhou H.; Characteristics of insulin-degrading enzyme in Alzheimer's disease: A meta-analysis. Curr Alzheimer Res 2018,15(7),610-617","journal-title":"Curr Alzheimer Res"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.neurobiolaging.2010.07.005","volume":"33","author":"Reitz C.","year":"2012","unstructured":"Reitz C.; Cheng R.; Schupf N.; Association between variants in IDE-KIF11-HHEX and plasma amyloid \u03b2 levels. Neurobiol Aging 2012,33(1),199-e13","journal-title":"Neurobiol Aging"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1002\/ajmg.b.32073","volume":"159B","author":"Hamilton G.","year":"2012","unstructured":"Hamilton G.; Harris S.E.; Davies G.; The role of ECE1 variants in cognitive ability in old age and Alzheimer's disease risk. Am J Med Genet B Neuropsychiatr Genet 2012,159B(6),696-709","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/S0002-9440(10)63822-9","volume":"162","author":"Cook D.G.","year":"2003","unstructured":"Cook D.G.; Leverenz J.B.; McMillan P.J.; Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer's disease is associated with the apolipoprotein E-epsilon4 allele. Am J Pathol 2003,162(1),313-319","journal-title":"Am J Pathol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1136\/jmg.2006.048470","volume":"44","author":"Veps\u00e4l\u00e4inen S.","year":"2007","unstructured":"Veps\u00e4l\u00e4inen S.; Parkinson M.; Helisalmi S.; Insulin-degrading enzyme is genetically associated with Alzheimer's disease in the Finnish population. J Med Genet 2007,44(9),606-608","journal-title":"J Med Genet"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1007\/s00439-001-0614-1","volume":"109","author":"Abraham R.","year":"2001","unstructured":"Abraham R.; Myers A.; Wavrant-DeVrieze F.; Substantial linkage disequilibrium across the insulin-degrading enzyme locus but no association with late-onset Alzheimer's disease. Hum Genet 2001,109(6),646-652","journal-title":"Hum Genet"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0304-3940(02)00586-4","volume":"329","author":"Boussaha M.","year":"2002","unstructured":"Boussaha M.; Hannequin D.; Verpillat P.; Brice A.; Frebourg T.; Campion D.; Polymorphisms of insulin degrading enzyme gene are not associated with Alzheimer's disease. Neurosci Lett 2002,329(1),121-123","journal-title":"Neurosci Lett"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3109\/00207454.2014.941440","volume":"125","author":"Cheng H.","year":"2015","unstructured":"Cheng H.; Wang L.; Shi T.; Shang Y.; Jiang L.; Association of insulin degrading enzyme gene polymorphisms with Alzheimer's disease: A meta-analysis. Int J Neurosci 2015,125(5),328-335","journal-title":"Int J Neurosci"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.tips.2017.10.008","volume":"39","author":"Kurochkin I.V.","year":"2018","unstructured":"Kurochkin I.V.; Guarnera E.; Berezovsky I.N.; Insulin-degrading enzyme in the fight against Alzheimer's disease. Trends Pharmacol Sci 2018,39(1),49-58","journal-title":"Trends Pharmacol Sci"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1097\/NEN.0b013e3181afe475","volume":"68","author":"Miners J.S.","year":"2009","unstructured":"Miners J.S.; Baig S.; Tayler H.; Kehoe P.G.; Love S.; Neprilysin and insulin-degrading enzyme levels are increased in Alzheimer disease in relation to disease severity. J Neuropathol Exp Neurol 2009,68(8),902-914","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.neulet.2013.01.051","volume":"541","author":"Zhang Y.","year":"2013","unstructured":"Zhang Y.; Wang B.; Wan H.; Zhou Q.; Li T.; Meta-analysis of the insulin degrading enzyme polymorphisms and susceptibility to Alzheimer's disease. Neurosci Lett 2013,541,132-137","journal-title":"Neurosci Lett"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s11064-020-03176-y","volume":"46","author":"Balcar V.J.","year":"2021","unstructured":"Balcar V.J.; Zeman T.; Janout V.; Janoutov\u00e1 J.; Lochman J.; \u0160er\u00fd O.; Single nucleotide polymorphism rs11136000 of CLU Gene (Clusterin, ApoJ) and the risk of late-onset Alzheimer's disease in a Central European Population. Neurochem Res 2021,46(2),411-422","journal-title":"Neurochem Res"},{"key":"ref=47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12929-018-0444-2","volume":"25","author":"H\u00e1lov\u00e1 A.","year":"2018","unstructured":"H\u00e1lov\u00e1 A.; Janoutov\u00e1 J.; Ewerlingov\u00e1 L.; CHAT gene polymorphism Rs3810950 is associated with the risk of Alzheimer's disease in the Czech population. J Biomed Sci 2018,25(1),1-9","journal-title":"J Biomed Sci"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jns.2016.01.022","volume":"362","author":"\u0160er\u00fd O.","year":"2016","unstructured":"\u0160er\u00fd O.; Hlineck\u00e1 L.; Povov\u00e1 J.; Arachidonate 5-lipoxygenase (ALOX5) gene polymorphism is associated with Alzheimer's disease and body mass index. J Neurol Sci 2016,362,27-32","journal-title":"J Neurol Sci"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/B978-0-12-815868-5.00004-9","author":"\u0160er\u00fd O.","year":"2020","unstructured":"\u0160er\u00fd O.; Goswami N.; Balcar V.J.;  In: Martin CR, Preedy VR, Eds Genetics, Neurology, Behavior, and Diet in Dementia: The Neuroscience of Dementia 2020,57-70","journal-title":"In: Martin CR, Preedy VR, Eds Genetics, Neurology, Behavior, and Diet in Dementia: The Neuroscience of Dementia"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1007\/s12035-020-02153-4","volume":"58","author":"Zeman T.","year":"2021","unstructured":"Zeman T.; Balcar V.J.; Cahov\u00e1 K.; Polymorphism Rs11867353 of tyrosine kinase non-receptor 1 (TNK1) gene is a novel genetic marker for Alzheimer's disease. Mol Neurobiol 2021,58(3),996-1005","journal-title":"Mol Neurobiol"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"Folstein M.F.","year":"1975","unstructured":"Folstein M.F.; Folstein S.E.; McHugh P.R.; \u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975,12(3),189-198","journal-title":"J Psychiatr Res"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S0022-2836(05)80360-2","volume":"215","author":"Altschul S.F.","year":"1990","unstructured":"Altschul S.F.; Gish W.; Miller W.; Myers E.W.; Lipman D.J.; Basic local alignment search tool. J Mol Biol 1990,215(3),403-410","journal-title":"J Mol Biol"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"D155","DOI":"10.1093\/nar\/gky1141","volume":"47","author":"Kozomara A.","year":"2019","unstructured":"Kozomara A.; Birgaoanu M.; Griffiths-Jones S.; miRBase: From microRNA sequences to function. Nucleic Acids Res 2019,47(D1),D155-D162","journal-title":"Nucleic Acids Res"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/j.cell.2006.07.031","volume":"126","author":"Miranda K.C.","year":"2006","unstructured":"Miranda K.C.; Huynh T.; Tay Y.; A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes. Cell 2006,126(6),1203-1217","journal-title":"Cell"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1136\/bmj.296.6632.1313","volume":"296","author":"Morris J.A.","year":"1988","unstructured":"Morris J.A.; Gardner M.J.; Calculating confidence intervals for relative risks (odds ratios) and standardised ratios and rates. Br Med J (Clin Res Ed) 1988,296(6632),1313-1316","journal-title":"Br Med J (Clin Res Ed)"},{"key":"ref=56","unstructured":"R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, 2018, Vienna, Austria. In: Available from: https:\/\/www.R-project.org\/"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12944-015-0123-1","volume":"14","author":"Sears B.","year":"2015","unstructured":"Sears B.; Perry M.; The role of fatty acids in insulin resistance. Lipids Health Dis 2015,14(1),1-9","journal-title":"Lipids Health Dis"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1139\/bcb-2015-0149","volume":"94","author":"Grimm M.O.W.","year":"2016","unstructured":"Grimm M.O.W.; Mett J.; Stahlmann C.P.; Eicosapentaenoic acid and docosahexaenoic acid increase the degradation of amyloid-\u03b2 by affecting insulin-degrading enzyme. Biochem Cell Biol 2016,94(6),534-542","journal-title":"Biochem Cell Biol"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1097\/00019442-200502000-00005","volume":"13","author":"Beeri M.S.","year":"2005","unstructured":"Beeri M.S.; Davidson M.; Silverman J.M.; Noy S.; Schmeidler J.; Goldbourt U.; Relationship between body height and dementia. Am J Geriatr Psychiatry 2005,13(2),116-123","journal-title":"Am J Geriatr Psychiatry"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1192\/bjp.bp.113.142984","volume":"205","author":"Russ T.C.","year":"2014","unstructured":"Russ T.C.; Kivim\u00e4ki M.; Starr J.M.; Stamatakis E.; Batty G.D.; Height in relation to dementia death: Individual participant meta-analysis of 18 UK prospective cohort studies. Br J Psychiatry 2014,205(5),348-354","journal-title":"Br J Psychiatry"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"691","DOI":"10.3233\/JAD-170528","volume":"60","author":"Larsson S.C.","year":"2017","unstructured":"Larsson S.C.; Traylor M.; Burgess S.; Markus H.S.; Genetically-predicted adult height and Alzheimer's disease. J Alzheimer's Dis 2017,60(2),691-698","journal-title":"J Alzheimer's Dis"},{"key":"ref=62","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3389\/fnins.2020.00669","volume":"14","author":"Levin R.A.","year":"2020","unstructured":"Levin R.A.; Carnegie M.H.; Celermajer D.S.; Pulse pressure: An emerging therapeutic target for dementia. Front Neurosci-Switz 2020,14,669","journal-title":"Front Neurosci-Switz"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3233\/JAD-141884","volume":"44","author":"Stone J.","year":"2015","unstructured":"Stone J.; Johnstone D.M.; Mitrofanis J.; ORourke M.; The mechanical cause of age-related dementia (Alzheimer's disease): The brain is destroyed by the pulse. J Alzheimer's Dis 2015,44(2),355-373","journal-title":"J Alzheimer's Dis"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1097\/00004872-200303000-00019","volume":"21","author":"Langenberg C.","year":"2003","unstructured":"Langenberg C.; Hardy R.; Kuh D.; Wadsworth M.E.J.; Influence of height, leg and trunk length on pulse pressure, systolic and diastolic blood pressure. J Hypertens 2003,21(3),537-543","journal-title":"J Hypertens"},{"key":"ref=65","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.flm.2019.07.001","volume":"2","author":"Shia Q.","year":"2018","unstructured":"Shia Q.; Ge D.; Yang Q.; Wang L.; Fu J.; MicroRNA profiling of cerebrospinal fluid from patients with intracerebral haemorrhage. Front Lab Med 2018,2(4),141-145","journal-title":"Front Lab Med"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.genrep.2018.03.015","volume":"11","author":"Priyanka P.","year":"2018","unstructured":"Priyanka P.; Panagal M.; Sivakumar P.; Identification, expression, and methylation of miR-7110 and its involvement in type 1 diabetes mellitus. Gene Rep 2018,11,229-234","journal-title":"Gene Rep"}],"container-title":["Current Alzheimer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1567205019666220302120950","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/201598\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1567205019666220302120950","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T21:28:22Z","timestamp":1691789302000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/201598\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":66,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1567205019666220302120950","relation":{},"ISSN":["1567-2050"],"issn-type":[{"type":"print","value":"1567-2050"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-11-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-07","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}